Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
Stock
02256
02256 News & Events
-
Add to Watchlist
Trade 02256
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
02256 News
Abbisko Therapeutics' NDA for Pimicotinib Accepted by FDA, Promising Significant Tumor Treatment Improvements
Jan 13 2026
PRnewswire
Abbisko Therapeutics' NDA for Pimicotinib Accepted by FDA, Significant Tumor Treatment Improvement
Jan 13 2026
Yahoo Finance
<Research>CMSI Forecasts Modest Economic Growth in the US Next Year; Hong Kong Stock Market to Transition Towards Earnings-Driven Performance
Dec 11 2025
aastocks
<M Stanley Analysis: Ratings and Target Prices for Biotech Companies (Table)>
Sep 22 2025
aastocks
M Stanley: Rising Recognition Drives Biotech Stocks to Surpass Market Performance
Sep 22 2025
aastocks
02256 Events
No data
02256 Monitor News
No data
02256 Earnings Analysis
No Data
People Also Watch
